Dr. Sharon Orrange - February 20, 2018
After practicing medicine for 20 years, I’ve become adept at “clarifying” to life insurance companies why patients are taking certain medications. The same medications appear to trigger red flags for both long-term care and life insurance companies.
Their “concern” makes sense for some medications because they are used for serious chronic illnesses, but for others, the insurance companies are worried about your lifestyle. See More
Elizabeth Davis - January 28, 2016
The new Goodrx Top 10 Lists are in, and this time we take a look back at the end of 2015. These are the most popular and most expensive drugs in the US, and they cover all kinds of conditions from common heart and pain meds to pricey treatments for cancer and genetic disorders.
To start with—which drugs were filled the most in the last quarter of 2015?
Elizabeth Davis - December 29, 2015
2015 was another tough year for American’s health care budgets. Insurance premiums increased, coverage was dropped for a number of important drugs, and overall we’re spending more for our health care.
Don’t break out the antidepressants yet—it’s not all bad news. A number of important drugs went generic, which will generally mean huge savings and lower costs. Plus, a large number of drugs actually decreased in price. See More
Elizabeth Davis - October 08, 2015
With all the news about high drug prices recently—which drugs are actually costing Americans the most money? What about the prescriptions that are being used the most? Take a look, and we’ll guide you through the highlights of the new GoodRx Top 10s, based on a sample of claims reported by pharmacies across the country.
Which drugs are the most expensive?
- Treatments for rare diseases make up a good portion of the list, particularly for hereditary angioedema (HAE). See More
Roni Shye - September 30, 2015
If you’ve been following the news, huge price increases on necessary drugs like Daraprim and cycloserine may seem unusual—they both dropped in price again once people noticed and complained, right?
The unfortunate reality as that price increases happen in the pharmaceutical industry day-in and day-out. While the majority aren’t quite as dramatic as the Daraprim price hike, they happen more often than you might think. See More
Elizabeth Davis - June 05, 2015
Our new top 10 lists are in for the most-dispensed and most expensive prescriptions in the US—take a look at these interesting updates.
Which prescriptions have been filled the most in 2015 so far?
Based on a sample of claims reported by pharmacies across the country, thyroid meds like Synthroid and levothyroxine near the top of the list, while standard heart and diabetes prescriptions lisinopril (Zestril, Prinivil), atorvastatin (Lipitor), and metformin (Glucophage) are still very frequently prescribed—no surprises there. See More
Elizabeth Davis - February 06, 2015
We’ve updated our lists of the Top 10 most-dispensed and most expensive prescriptions in the US, with some interesting changes from the end of 2014.
Curious about the most popular prescriptions?
Based on a sample of claims reported by pharmacies across the country, some common antibiotics, like amoxicillin (Amoxil) and azithromycin (Zithromax) top the list, along with heart meds like atorvastatin (Lipitor) and lisinopril (Zestril, Prinivil). See More
Roni Shye - January 14, 2015
In the past year, the realm of hepatitis C treatment has been flourishing. Several new medications have received FDA approval and have changed the way we treat this often silent disease.
With the introduction of new first line treatments, slowly but surely, we will begin to see the discontinuation of many older hepatitis C treatments. Incivek was pulled by its manufacturer, Vertex Pharmaceuticals, back in October. See More
Roni Shye - January 05, 2015
Viekira Pak was approved by the FDA on December 19, 2015 as the newest treatment for chronic hepatitis C (genotype 1), and is already available to patients. Genotype 1 is the most common in the US, affecting around 75% of Americans with the virus.
Were there any special circumstances for the approval of Viekira Pak?